Clozapine Prolongs Cortical Silent Period in Patients with Treatment-Resistant Schizophrenia

OBJECTIVES: Although clozapine exhibited high efficacy for treating the symptoms of patients with treatment-resistant schizophrenia (TRS), its precise action mechanisms have not been fully understood. Recently, accumulating evidence has suggested the presence of abnormalities in the gamma-aminobutyr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Psychopharmacol Bull
Autors principals: Miyazawa, Atsuhiro, Kanahara, Nobuhisa, Nakata, Yusuke, Kodama, Satoshi, Kimura, Hiroshi, Kimura, Atsushi, Oda, Yasunori, Watanabe, Hiroyuki, Iyo, Masaomi
Format: Artigo
Idioma:Inglês
Publicat: MedWorks Media Global 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8146563/
https://ncbi.nlm.nih.gov/pubmed/34092820
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars